Partner
Alissa Lipton’s practice involves representing biotechnology and pharmaceutical companies in patent proceedings in district courts, before the U.S. Court of Appeals for the Federal Circuit, and before the U.S. Patent and Trademark Office (USPTO). Her practice also involves strategic client counseling, including due diligence and opinion work, and portfolio management.
Alissa has almost two decades of experience representing companies in patent litigation, from pre-litigation analysis through appeal to the Federal Circuit. She also provides strategic counsel to clients in technologies including therapeutic antibodies, CRISPR, antisense technologies, diagnostics, and small molecules. Alissa’s practice includes due diligence, freedom-to-operate, enforceability, and infringement assessments.
Alissa served at the Federal Circuit as a law clerk for the Honorable Alvin A. Schall. She has represented veterans before the U.S. Court of Appeals for Veterans Claims.
Alissa was recognized as a Boston, Massachusetts, “Rising Star” by The National Law Journal, and as an “Up and Coming Attorney” for Excellence in the Law by Massachusetts Lawyers Weekly. She was also named a client service all-star by BTI Consulting Group. Alissa frequently writes and presents on patent law topics and is the coauthor of Court of Appeals for the Federal Circuit: Practice and Procedure. She is also a contributing author of Patent Litigation Strategies Handbook, published by the American Bar Association Section of Intellectual Property Law and Bloomberg BNA.
Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.
Represented Sarepta Therapeutics, Inc. and its licensor The University of Western Australia in patent litigation relating to nucleic acid therapies for treatment of Duchenne muscular dystrophy (DMD). A federal jury in the District of Delaware awarded Sarepta Therapeutics over $115 million in its patent infringement case against Nippon Shinyaku Co. Ltd. This substantial verdict upholds the validity of Sarepta's groundbreaking exon-skipping treatment, and the underlying work at the University of Western Australia.
1:21-cv-01015, D. Del., Judges Hall, Williams
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
Successfully represented Eli Lilly in defensive patent litigation and in offensive inter partes reviews (IPRs) regarding products related to the treatment of migraines.
IPR2022-00738, -00739, -00796, PTAB, Judges Cotta, Wisz, Worth
1:21-cv-10954, D. Mass., Judge Burroughs
Boston Heart Diagnostics Corp. v. Health Diagnostic Laboratories
Represented Health Diagnostic Laboratories in litigation in a suit brought by an exclusive licensee relating to SLCO1B1 genetic tests for statin-induced myopathy.
1:13-cv-13111, D. Mass., Judges Bowler, Saylor, Talwani
iRobot Corporation v. SharkNinja Operating LLC et al.
1:19-cv-12125, D. Mass., Judge Burroughs
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
1:16-cv-00596, S.D. Ind., Judges Pratt, Brookman
CardioNet LLC et al. v. InfoBionic, Inc.
1:17-cv-10445, D. Mass., Judge Talwani
Conference
New Jersey Intellectual Property Law Association 39th Annual Pharmaceutical/Chemical Patent Practice Update New Jersey Intellectual Property Law Association 39th Annual Pharmaceutical/Chemical Patent Practice Update
November 11, 2025
Newark
IP Updates
D. Mass. Local Patent Rules: Where Are We Seven Years After Amendment of the Local Patent Rule? D. Mass. Local Patent Rules: Where Are We Seven Years After Amendment of the Local Patent Rule?
May 5, 2025
Seminar
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 1, 2025
Cambridge
Articles
D. Mass. Patent Litigation Update: October 2024 D. Mass. Patent Litigation Update: October 2024
December 4, 2024
Articles
D. Mass. Patent Litigation Update: July 2024 D. Mass. Patent Litigation Update: July 2024
September 10, 2024
Articles
D. Mass. Patent Litigation Update: May 2024 D. Mass. Patent Litigation Update: May 2024
June 28, 2024
"Patent litigator Alissa K. Lipton is known for her exceptional legal writing and advocacy as well as for her pro bono work with veterans appealing disability denials. She has co-authored two widely-used publications, including a practice and procedure treatise for the U.S. Court of Appeals for the Federal Circuit.”
Massachusetts Lawyers Weekly
"Patent litigator Alissa K. Lipton is known for her exceptional legal writing and advocacy as well as for her pro bono work with veterans appealing disability denials. She has co-authored two widely-used publications, including a practice and procedure treatise for the U.S. Court of Appeals for the Federal Circuit.”
Massachusetts Lawyers Weekly
Award/Ranking
Two Finnegan Partners Named BTI Client Service All-Stars Two Finnegan Partners Named BTI Client Service All-Stars
June 10, 2024
BTI Consulting GroupMedia Mention
Litigator of the Week Runners-Up and Shout Outs: Siemens Gamesa Renewable Energy Litigator of the Week Runners-Up and Shout Outs: Siemens Gamesa Renewable Energy
September 16, 2022
The AmLaw Litigation DailyMedia Mention
GE Banned from Selling Wind Turbines Infringing Siemens' IP GE Banned from Selling Wind Turbines Infringing Siemens' IP
September 7, 2022
Law360Media Mention
Mass. Jury Says GE Infringed Siemens Wind Turbine Patent Mass. Jury Says GE Infringed Siemens Wind Turbine Patent
June 17, 2022
Law360Media Mention
iRobot Can't Halt SharkNinja Vacuum Sales During IP Suit iRobot Can't Halt SharkNinja Vacuum Sales During IP Suit
November 26, 2019
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.